Concepedia

Publication | Open Access

Chk1 as a new therapeutic target in triple-negative breast cancer

61

Citations

37

References

2014

Year

Abstract

These findings suggest that Chk1 may represent a therapeutic target in TNBC, and provide a rationale to evaluate Chk1 inhibitors in breast cancer patients.

References

YearCitations

Page 1